Patent · US Active

Methods and compositions for RNA-guided treatment of HIV infection

US11298410B2 · kind B2 · utility

0Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 1, 2016
Grant dateApr 12, 2022
Priority date
Expiry dateJun 1, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/11
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions for specifically cleaving target sequences in retroviruses include nucleic acids encoding a Clustered Regularly Interspace Short Palindromic Repeat (CRISPR) associated endonuclease and a guide RNA sequence complementary to one or more target nucleic acid sequences in a retrovirus genome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.